EUVIMEDEUVIMED entdecken
EditorialOpen Access

Global child-friendly anti-TB medicines – where do we stand?

H S Schaaf, D T Wademan, L E van der Laan

IJTLD Open · 2025-09 · 2 (9) · 501-504

DOI: 10.5588/ijtldopen.25.0446 ↗

Kurz gefasst

Editorial in der Zeitschrift IJTLD Open, online erschienen am 01.09.2025. Verfasst von H S Schaaf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Sout…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An increasing number of children are diagnosed and started on antituberculosis treatment. Despite progress in developing child-friendly antituberculosis formulations for drug-susceptible and drug-resistant TB, a single-medicine rifampicin dispersible tablet is still needed. Further, many child-friendly dispersible solid-tablet formulations are not available globally. Access challenges lead to formulation manipulation of adult tablets, including the development of extemporaneous solutions, supported by pharmacokinetic studies to dose young children. Preparing extemporaneous formulations need pharmacies and trained staff. Therefore, a need remains for global collaboration to prioritise child-friendly solid, dispersible, functionally scored TB formulations and to ensure equal access for all children with TB globally.

Schlagwörter

Stichwörter der Autor:innen

bedaquilineclofaziminedelamaniddispersibleextemporaneousfluoroquinolonesformulation manipulationpretomanidtuberculosis

Autor:innen und Institutionen

  • Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Zitieren

APA

Schaaf, H. S., Wademan, D. T., & van der Laan, L. E. (2025). Global child-friendly anti-TB medicines – where do we stand?. IJTLD Open, 2(9), 501-504. https://doi.org/10.5588/ijtldopen.25.0446

Vancouver

Schaaf HS, Wademan DT, van der Laan LE. Global child-friendly anti-TB medicines – where do we stand?. IJTLD Open. 2025;2(9):501-504. doi:10.5588/ijtldopen.25.0446

BibTeX
@article{Schaaf2025,
  author = {Schaaf, H S and Wademan, D T and van der Laan, L E},
  title = {Global child-friendly anti-TB medicines – where do we stand?},
  journal = {IJTLD Open},
  year = {2025},
  volume = {2},
  number = {9},
  pages = {501--504},
  doi = {10.5588/ijtldopen.25.0446}
}
Kostenlos starten →